Literature DB >> 12492762

An evaluation of the Dartmouth Assessment of Lifestyle Inventory and the Leeds Dependence Questionnaire for use among detained psychiatric inpatients.

Peter Ford1.   

Abstract

AIM: To examine the psychometric properties of the Dartmouth Assessment of Lifestyle Inventory (DALI) as a substance use disorder screening instrument, and the Leeds Dependency Questionnaire (LDQ) as a measure of severity of dependence among inpatients with severe mental disorders detained in hospital.
DESIGN: Comparison of DALI scores, LDQ scores and a clinical assessment of substance use disorder. Statistical analysis calculated Cronbach's alpha, receiver operator characteristics, anova and multivariate linear regression.
SETTING: An English medium secure psychiatric hospital. PARTICIPANTS: A random sample of 60 adult inpatients with one or more diagnoses of schizophrenia, personality disorder and mild to moderate learning difficulty. MEASUREMENTS: All participants completed the LDQ, DALI and a clinical assessment of substance use disorder using ICD-10 criteria.
FINDINGS: The diagnostic accuracy of the DALI instrument was 74% for alcohol disorders and 83% for drug disorders. The reliability of the LDQ and concurrent validity with the DALI were good (a = 0.915, R2 = 0.439, F (2, 57) = 22.3, P < 0.001).
CONCLUSIONS: The DALI's overall accuracy for screening inpatients is good, but it under-diagnosed substance use disorders, probably because the hospital environment moderates substance use. The results suggest that the LDQ has very good psychometric properties and is useful as a measure of substance dependence in this population. Furthermore, the validity of the LDQ in this clinical population provides evidence to suggest the same cognitive and behavioural processes of addiction operate among those inpatients with severe mental disorders detained in psychiatric hospital as in the general population.

Entities:  

Mesh:

Year:  2003        PMID: 12492762     DOI: 10.1046/j.1360-0443.2003.00313.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  5 in total

1.  Insomnia and suicidal ideation in nonaffective psychosis.

Authors:  Brian J Miller; Carmen B Parker; Mark H Rapaport; Peter F Buckley; William V McCall
Journal:  Sleep       Date:  2019-02-01       Impact factor: 5.849

2.  Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses.

Authors:  Brian J Miller; Prianka Kandhal; Mark Hyman Rapaport; Andrew Mellor; Peter Buckley
Journal:  Brain Behav Immun       Date:  2014-12-24       Impact factor: 7.217

3.  Screening for substance use disorders in first-episode psychosis: implications for readmission.

Authors:  Albert Batalla; Clemente Garcia-Rizo; Pere Castellví; Emili Fernandez-Egea; Murat Yücel; Eduard Parellada; Brian Kirkpatrick; Rocío Martin-Santos; Miguel Bernardo
Journal:  Schizophr Res       Date:  2013-03-19       Impact factor: 4.939

4.  Measuring clinically significant outcomes - LDQ, CORE-10 and SSQ as dimension measures of addiction.

Authors:  Duncan Raistrick; Gillian Tober; Jenny Sweetman; Sally Unsworth; Helen Crosby; Tom Evans
Journal:  Psychiatr Bull (2014)       Date:  2014-06

5.  Factor analysis of treatment outcomes from a UK specialist addiction service: relationship between the Leeds Dependence Questionnaire, Social Satisfaction Questionnaire and 10-item Clinical Outcomes in Routine Evaluation.

Authors:  Caroline Fairhurst; Jan R Böhnke; Rhian Gabe; Tim J Croudace; Gillian Tober; Duncan Raistrick
Journal:  Drug Alcohol Rev       Date:  2014-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.